Affinity of 22-oxa-1,25(OH)2D3 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells

This publication has 21 references indexed in Scilit:

• Effect of 1,25(OH)2D3 on its receptor mRNA levels and osteocalcin synthesis in human osteosarcoma cells
  Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1990
• A SYNTHETIC ANALOGUE OF VITAMIN D₃, 22-OXA-lα,25-DIHYDROXYVITAMIN D₃IS A POTENT MODULATOR OF IN VIVO IMMUNOREGULATING ACTIVITY WITHOUT INDUCING HYPERCALCEMIA IN MICE
  Endocrinology, 1989
• Resistance to 1,25-Dihydroxyvitamin D₃of Cultured Psoriatic Epidermal Keratinocytes Isolated from Involved and Uninvolved Skin*
  Journal of Clinical Endocrinology & Metabolism, 1989
• 1,25(OH) ₂ ‐Vitamin D ₃ receptors: gene regulation and genetic circuitry
  The FASEB Journal, 1988
• 1α,25 (OH)2 vitamin D3: A steroid hormone capable of producing pleiotropic receptor-mediated biological responses by both genomic and nongenomic mechanisms
  Journal of Steroid Biochemistry, 1988
• Synthetic analogues of vitamin D₃ with an oxygen atom in the side chain skeleton A trial of the development of vitamin D compounds which exhibit potent differentiation‐inducing activity without inducing hypercalcemia
  FEBS Letters, 1987
• Characterization of a human osteoblastic osteosarcoma cell line (SAOS-2) with high bone alkaline phosphatase activity
  Journal of Bone and Mineral Research, 1987
• Synthetic studies of vitamin D3 analogues. VIII Synthesis of 22-oxavitamin D3 analogues.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
• Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids
  Metabolic Bone Disease and Related Research, 1984
• Mechanism of action of 1,25-dihydroxyvitamin D3-induced stimulation of alkaline phosphatase in cultured osteoblast-like cells
  Molecular and Cellular Endocrinology, 1983